ClinicalTrials.gov is getting its first makeover in years! Follow along as we review what's new and exciting, and where it falls short.
New $6.3B legislation passed by congress may cause crackdowns in the area of $500,000 for non-compliant clinical trial teams. Read more.
The 21st Century Cures Laws is changing the definitions and roles of clinical trial sponsors in the clinical development process. Here's what you need to know.
The hardest part of the clinical trial process is recruitment. A new study from Tufts explains how data-sharing may make recruiting easier for the industry.
The HHS is imposing new laws related to trial disclosure and failing to comply could cost teams up to $500,000. Read more.
Trial transparency is a hot topic in the industry. Results-sharing rates are too low. Our data suggests the issue is even worse with pediatric clinical trials.
Getting approval from the NIH on a trial used to feel like a sure thing, but these charts imply the approval process is getting longer and more difficult.
Read about the recent FDA meeting that reviewed the value of expansion cohorts in phase I trials, and what this means for investigators and sponsors.